Therefore, GLP-1 may reduce the likelihood of non-alcoholic fatty liver disease (NAFLD) in individuals with T2DM by directly interacting with hepatic GLP-1 receptors. The gene discussed is GCG; the disease is type 2 diabetes mellitus.